Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial
- Resource Type
- Article
- Authors
- Adams, Kirsty; Amini, Fahimah; Atako, Nafisah B; Bakri, Amalina; Barclay, Wendy; Brodnicki, Elizabeth; Brown, Jonathan C; Byrne, Ruth; Chilvers, Rowena; Coelho, Sofia; Day, Suzanne; Desai, Monica; Dorman, Eleanor; Elliott, Tamara; Flight, Katie E; Fletcher, James; Galang, John; Gohil, Jagruti; Gupta, Aneta; Harlow, Chris; Hu, Kai; Kalyan, Mohini; Lagrue, Dominic; Liscano, Ely; Njenga, Cecilia; Polra, Krunal; Powlette, Derecia A; Randell, Paul; Rauchenberger, Mary; Redknap, Ianto; Ricamara, Maravic; Rogers, Paul; Sallah, Hadijatou; Samnuan, Karnyart; Schumacher, Michael; Shah, Zareena; Shaw, Rachel; Shaw, Thomas; Sivapatham, Stefan; Slater, Susie; Sorley, Kim; Storch, Regina; Tan, Elizabeth; Tan, Tricia; Thielemans, Lieze; Whitely, Sarah; Valentine, Charlotte; Varghese, Jeeva; Vikraman, Asha; Wilkins, Martin; Pollock, Katrina M.; Cheeseman, Hannah M.; Szubert, Alexander J.; Libri, Vincenzo; Boffito, Marta; Owen, David; Bern, Henry; McFarlane, Leon R.; O'Hara, Jessica; Lemm, Nana-Marie; McKay, Paul; Rampling, Tommy; Yim, Yee Ting N.; Milinkovic, Ana; Kingsley, Cherry; Cole, Tom; Fagerbrink, Susanne; Aban, Marites; Tanaka, Maniola; Mehdipour, Savviz; Robbins, Alexander; Budd, William; Faust, Saul; Hassanin, Hana; Cosgrove, Catherine A.; Winston, Alan; Fidler, Sarah; Dunn, David; McCormack, Sheena; Shattock, Robin J.
- Source
- In eClinicalMedicine February 2022 44
- Subject
- Language
- ISSN
- 2589-5370